The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of fruquintinib plus mFOLFOX6/FOLFIRI as first-line therapy in advanced metastatic colorectal cancer (mCRC).
 
Fuxiang Zhou
No Relationships to Disclose
 
Wang Wen-bo
No Relationships to Disclose
 
Ling Xia
No Relationships to Disclose
 
Jing Dai
No Relationships to Disclose
 
Han Wu
No Relationships to Disclose
 
Lei Yang
No Relationships to Disclose
 
Zhiguo Xiong
No Relationships to Disclose
 
Jun Gong
No Relationships to Disclose